Significance of Microenvironment for Prostate Cancer Initiation and Progression

微环境对前列腺癌发生和进展的意义

基本信息

  • 批准号:
    7233446
  • 负责人:
  • 金额:
    $ 60万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-30 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Recently it has become evident that although it is the prostate epithelial cell that is transformed into prostate adenocarcinoma, the stromal components of the prostate strongly influence the transformation process and ultimate fate of the transformed cell. This program will define the components of the human prostate stromal microenvironment, the contribution of stromal and epithelial cells to this environment and effects of factors associated with induction of prostate cancer e.g. age, oxidative stress, inflammation product, on the stromal components, and mechanisms of action of selected components. Products arising from this program that will be available to the research community will include but are not limited to: functional blocking human monoclonal antibodies to matrix components, microarray and proteomic databases, preclinical models for evaluation of stromal factors on human tissue. This program will consist of three projects that include: 1. The Aged Microenvironment as a Contributor to Carcinogenesis :Aim 1: Identify molecular changes in the major cellular and matrix constituents of stroma that occur in association with aging. Aim 2: Determine the influence of specific age-associated stromal-derived paracrine factors toward tumor growth/ invasion/ differentiation. Aim 3: Determine if deficiencies in DMA repair mechanisms contribute to molecular aging in the tumor microenvironment. Aim 4. Evaluate hypothesis that aging/senescence of prostate stroma increases characteristics of wound/stress response (co-Aim with Plymate Project). 2. Paracrine and Juxtacrine Mediation of Prostate Cancer Progression : Aim 1. Use of tissue recombination to model cancer progression, Aim 2. Identification and characterization of mesenchymal regulators of prostate development. Aim 3. Juxtacrine signaling models involving tumor and senescent fibroblasts. 3. Laminin Dysregulation in Prostate Cancer: Aim1.Define the laminin chains and integrin subunits in normal and malignant prostate tissue. Aim 2. Determine function of laminin changes in prostate cancer. Aim 3. Determine age-induced changes in laminin, signaling and transcription on proteolytic remodeling of ECM with increased invasion of the mesenchyme. The purpose of this proposal is to define the effects of the prostate environment on development and progression of prostate cancer. Also we will determine how inhibition of these microenvironmental factors can be used as potential therapy for prostate cancer prevention and progression.
描述(由申请人提供):最近发现,虽然是前列腺上皮细胞转化为前列腺

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephen R. Plymate其他文献

Seminal Fluid Androgen Binding Protein
精液雄激素结合蛋白
  • DOI:
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    2.4
  • 作者:
    Stephen R. Plymate;B. Fariss;M. L. Smith;W. H. Jacob;L. Matej
  • 通讯作者:
    L. Matej
Identification de la sensibilité aux taxanes chez des patients atteints d'un cancer de la prostate
前列腺癌患者的紫杉烷敏感性鉴定
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Paraskevi Giannakakou;Stephen R. Plymate
  • 通讯作者:
    Stephen R. Plymate
Weight loss is associated with correction of gonadotropin and sex steroid abnormalities in the obese anovulatory female.
体重减轻与肥胖无排卵女性的促性腺激素和性类固醇异常的纠正有关。
  • DOI:
    10.1016/s0015-0282(16)48154-9
  • 发表时间:
    1984
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    Frederick E. Harlass;Stephen R. Plymate;B. Fariss;Richard P. Belts
  • 通讯作者:
    Richard P. Belts
Visually stimulated erection in castrated men.
视觉刺激阉割男性的勃起。
  • DOI:
    10.1016/s0022-5347(01)67675-4
  • 发表时间:
    1995
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Alexander Greenstein;Stephen R. Plymate;P. Katz
  • 通讯作者:
    P. Katz
Circadian variation in testosterone, sex hormone-binding globulin, and calculated non-sex hormone-binding globulin bound testosterone in healthy young and elderly men.
健康年轻和老年男性睾酮、性激素结合球蛋白和计算出的非性激素结合球蛋白结合睾酮的昼夜节律变化。
  • DOI:
  • 发表时间:
    1989
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Stephen R. Plymate;J. S. Tenover;W. J. Bremner
  • 通讯作者:
    W. J. Bremner

Stephen R. Plymate的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephen R. Plymate', 18)}}的其他基金

Targeting the Metabolome in Androgen Receptor-driven Castration-resistant Prostate Cancer
靶向雄激素受体驱动的去势抵抗性前列腺癌的代谢组
  • 批准号:
    10455421
  • 财政年份:
    2016
  • 资助金额:
    $ 60万
  • 项目类别:
Targeting the Metabolome in Androgen Receptor-driven Castration-resistant Prostate Cancer
靶向雄激素受体驱动的去势抵抗性前列腺癌的代谢组
  • 批准号:
    10015557
  • 财政年份:
    2016
  • 资助金额:
    $ 60万
  • 项目类别:
Targeting the Metabolome in Androgen Receptor-driven Castration-resistant Prostate Cancer
靶向雄激素受体驱动的去势抵抗性前列腺癌的代谢组
  • 批准号:
    10620272
  • 财政年份:
    2016
  • 资助金额:
    $ 60万
  • 项目类别:
Development of Castration Resistance by Alternative AR Splicing
通过选择性 AR 拼接开发去势抵抗力
  • 批准号:
    8475912
  • 财政年份:
    2013
  • 资助金额:
    $ 60万
  • 项目类别:
P-4: Mechanisms by Which the T1 Insulin-like Growth Factor Inhibition Enhances
P-4:T1 胰岛素样生长因子抑制增强的机制
  • 批准号:
    8130549
  • 财政年份:
    2010
  • 资助金额:
    $ 60万
  • 项目类别:
Mechanisms for the Transition to Castrate Resistant Prostate Cancer
向去势抵抗性前列腺癌转变的机制
  • 批准号:
    8391557
  • 财政年份:
    2009
  • 资助金额:
    $ 60万
  • 项目类别:
Mechanisms for the Transition to Castrate Resistant Prostate Cancer
向去势抵抗性前列腺癌转变的机制
  • 批准号:
    7921471
  • 财政年份:
    2009
  • 资助金额:
    $ 60万
  • 项目类别:
Mechanisms for the Transition to Castrate Resistant Prostate Cancer
向去势抵抗性前列腺癌转变的机制
  • 批准号:
    7796470
  • 财政年份:
    2009
  • 资助金额:
    $ 60万
  • 项目类别:
Mechanisms for the Transition to Castrate Resistant Prostate Cancer
向去势抵抗性前列腺癌转变的机制
  • 批准号:
    8195899
  • 财政年份:
    2009
  • 资助金额:
    $ 60万
  • 项目类别:
Mechanisms by Which the Type 1 Insulin-like Growth Factor Inhibition Enhances
1 型胰岛素样生长因子抑制增强的机制
  • 批准号:
    7314894
  • 财政年份:
    2007
  • 资助金额:
    $ 60万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 60万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了